| |
| |
|
| Insider
Information: |
Keane Raymond T |
| Relationship: |
SVP General Counsel & ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
62,096 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,096 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP General Counsel & ... |
2013-07-18 |
62,096 |
2010-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-07-18 |
4 |
AS |
$19.79 |
$158,286 |
D/D |
(8,000) |
62,096 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,000 |
70,096 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-04-02 |
4 |
S |
$18.05 |
$46,625 |
D/D |
(2,583) |
54,096 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,166 |
56,679 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-03-25 |
4 |
S |
$18.87 |
$248,482 |
D/D |
(13,167) |
51,513 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-03-22 |
4 |
S |
$19.46 |
$45,423 |
D/D |
(2,334) |
38,347 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
64,680 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2013-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
40,681 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$65,302 |
D/D |
(3,236) |
36,014 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,750 |
39,250 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-09-06 |
4 |
AS |
$22.00 |
$220,000 |
D/D |
(10,000) |
31,500 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-09-06 |
4 |
OE |
$2.39 |
$23,900 |
D/D |
10,000 |
41,500 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-09-04 |
4 |
AS |
$21.00 |
$163,380 |
D/D |
(7,780) |
31,500 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-08-15 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
39,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-08-15 |
4 |
OE |
$2.39 |
$23,900 |
D/D |
10,000 |
49,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-07-30 |
4 |
AS |
$19.00 |
$190,000 |
D/D |
(10,000) |
39,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-07-26 |
4 |
AS |
$18.00 |
$180,000 |
D/D |
(10,000) |
49,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• • – |
2012-07-26 |
4 |
OE |
$2.39 |
$23,900 |
D/D |
10,000 |
59,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-03-23 |
4 |
AS |
$15.41 |
$162,271 |
D/D |
(10,533) |
45,880 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
56,713 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-03-20 |
4 |
S |
$15.02 |
$126,155 |
D/D |
(8,400) |
30,380 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,000 |
38,780 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-02-14 |
4 |
AS |
$15.13 |
$189,178 |
D/D |
(12,500) |
17,780 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2012-02-14 |
4 |
OE |
$1.30 |
$16,250 |
D/D |
12,500 |
30,280 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP General Counsel & CCO |
• – – |
2011-03-22 |
4 |
D |
$6.39 |
$54,660 |
D/D |
(8,554) |
17,780 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
